# FLUORESCEIN SODIUM
> **ANDA220046** · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS · Approved 2026-04-30
## Drug
- **FDA Application Number:** ANDA220046
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUORESCEIN SODIUM
- **Generic name:** Fluorescein Sodium
- **Active ingredients:** FLUORESCEIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BPI LABS
- **First approval:** 2026-04-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220046)
---
*AI Analytics · CC0 1.0*